|
US338109A
(en)
*
|
|
1886-03-16 |
|
Clothes-fork |
|
US2987445A
(en)
*
|
1958-10-10 |
1961-06-06 |
Rohm & Haas |
Drug composition
|
|
US3087860A
(en)
*
|
1958-12-19 |
1963-04-30 |
Abbott Lab |
Method of prolonging release of drug from a precompressed solid carrier
|
|
US3336200A
(en)
*
|
1963-05-28 |
1967-08-15 |
Warner Lambert Pharmaceutical |
Tablet structure
|
|
IT1066857B
(it)
*
|
1965-12-15 |
1985-03-12 |
Acraf |
Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
|
|
US3652589A
(en)
*
|
1967-07-27 |
1972-03-28 |
Gruenenthal Chemie |
1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
|
|
GB1368574A
(en)
|
1971-02-12 |
1974-10-02 |
Ives Lab Inc |
Divisible tablet
|
|
US4131675A
(en)
|
1978-02-09 |
1978-12-26 |
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. |
Use of combinations of L-DOPA with trazodone and L-DOPA with etoperidone in Parkinsonism
|
|
US4353887A
(en)
|
1979-08-16 |
1982-10-12 |
Ciba-Geigy Corporation |
Divisible tablet having controlled and delayed release of the active substance
|
|
US4465660A
(en)
*
|
1981-04-01 |
1984-08-14 |
Mead Johnson & Company |
Sustained release tablet containing at least 95 percent theophylline
|
|
DE3314003A1
(de)
*
|
1983-04-18 |
1984-10-18 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
|
|
US4824677A
(en)
*
|
1986-12-18 |
1989-04-25 |
The Unjohn Company |
Grooved tablet for fractional dosing of sustained release medication
|
|
FR2618073B1
(fr)
|
1987-07-16 |
1990-09-07 |
Pf Medicament |
Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation
|
|
US4820522A
(en)
*
|
1987-07-27 |
1989-04-11 |
Mcneilab, Inc. |
Oral sustained release acetaminophen formulation and process
|
|
US5004613A
(en)
*
|
1987-07-27 |
1991-04-02 |
Mcneil-Ppc, Inc. |
Oral sustained release pharmaceutical formulation and process
|
|
US4968509A
(en)
|
1987-07-27 |
1990-11-06 |
Mcneilab, Inc. |
Oral sustained release acetaminophen formulation and process
|
|
IT1233412B
(it)
*
|
1987-12-02 |
1992-03-30 |
Acraf |
Uso del trazodone
|
|
US4938968A
(en)
*
|
1988-07-26 |
1990-07-03 |
Norjec Development Associates, Inc. |
Controlled release indomethacin
|
|
US5126145A
(en)
*
|
1989-04-13 |
1992-06-30 |
Upsher Smith Laboratories Inc |
Controlled release tablet containing water soluble medicament
|
|
US5133974A
(en)
*
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
CA2041774C
(en)
|
1990-11-27 |
1994-04-19 |
Mircea A. Mateescu |
Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
|
|
US5603956A
(en)
*
|
1990-11-27 |
1997-02-18 |
Labopharm Inc. |
Cross-linked enzymatically controlled drug release
|
|
DK0566709T5
(da)
*
|
1991-09-06 |
2009-05-18 |
Ortho Mcneil Janssen Pharm |
Præparat indeholdende et tramadolmateriale og acetaminophen og anvendelse deraf
|
|
JPH0719339Y2
(ja)
|
1991-10-07 |
1995-05-10 |
東ポリ株式会社 |
線金衣服ハンガー
|
|
US5407686A
(en)
*
|
1991-11-27 |
1995-04-18 |
Sidmak Laboratories, Inc. |
Sustained release composition for oral administration of active ingredient
|
|
US5968551A
(en)
*
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
|
GB2284760B
(en)
|
1993-11-23 |
1998-06-24 |
Euro Celtique Sa |
A method of preparing pharmaceutical compositions by melt pelletisation
|
|
US5681585A
(en)
*
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
|
US5958459A
(en)
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
|
US5273760A
(en)
|
1991-12-24 |
1993-12-28 |
Euroceltigue, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5478577A
(en)
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
|
US5286493A
(en)
*
|
1992-01-27 |
1994-02-15 |
Euroceltique, S.A. |
Stabilized controlled release formulations having acrylic polymer coating
|
|
FR2688422A1
(fr)
|
1992-03-11 |
1993-09-17 |
Coletica |
Microcapsules a parois en polysaccharides contenant des fonctions alcools primaires, et compositions en contenant.
|
|
US5292534A
(en)
*
|
1992-03-25 |
1994-03-08 |
Valentine Enterprises, Inc. |
Sustained release composition and method utilizing xanthan gum and an active ingredient
|
|
RU2136270C1
(ru)
|
1992-07-24 |
1999-09-10 |
Лабофарм Инк. |
Твердая фармацевтическая форма
|
|
SE9202250D0
(sv)
*
|
1992-07-29 |
1992-07-29 |
Gacell Lab Ab |
Controlled release morphine preparation
|
|
IL103096A
(en)
*
|
1992-09-08 |
1996-12-05 |
Chemagis Ltd |
Process for purification 2 -]) Dimethylamino (methyl-1-) 3-methoxycinyl (cyclohexanol and its salts.
|
|
FR2698560B1
(fr)
|
1992-11-30 |
1995-02-03 |
Virbac Laboratoires |
Principes actifs pulvérulents stabilisés, compositions les contenant, leur procédé d'obtention et leurs applications.
|
|
US5616343A
(en)
*
|
1993-03-25 |
1997-04-01 |
Labopharm, Inc. |
Cross-linked amylose as a binder/disintegrant in tablets
|
|
NZ260408A
(en)
*
|
1993-05-10 |
1996-05-28 |
Euro Celtique Sa |
Controlled release preparation comprising tramadol
|
|
DE4315525B4
(de)
|
1993-05-10 |
2010-04-15 |
Euro-Celtique S.A. |
Pharmazeutische Zusammensetzung
|
|
IL110014A
(en)
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
|
IL109944A
(en)
|
1993-07-01 |
1998-12-06 |
Euro Celtique Sa |
Sustained release dosage unit forms containing morphine and a method of preparing these sustained release dosage unit forms
|
|
US5879705A
(en)
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
|
KR100297175B1
(ko)
|
1993-08-24 |
2001-10-24 |
샬크비즈크 피이터 코르넬리스; 페트귄터 |
안과용렌즈
|
|
DE4329794C2
(de)
*
|
1993-09-03 |
1997-09-18 |
Gruenenthal Gmbh |
Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
|
|
JPH0719339U
(ja)
*
|
1993-09-07 |
1995-04-07 |
武田薬品工業株式会社 |
分割錠剤
|
|
US5773025A
(en)
*
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
|
US5451409A
(en)
|
1993-11-22 |
1995-09-19 |
Rencher; William F. |
Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
|
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
|
KR100354702B1
(ko)
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
|
DK0654263T3
(da)
|
1993-11-23 |
2002-04-29 |
Euro Celtique Sa |
Fremgangsmåde til fremstilling af et præparat med langvarig frigivelse
|
|
US6210714B1
(en)
*
|
1993-11-23 |
2001-04-03 |
Euro-Celtique S.A. |
Immediate release tablet cores of acetaminophen having sustained-release coating
|
|
US5843480A
(en)
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
|
US5560331A
(en)
|
1994-05-10 |
1996-10-01 |
Yamaha Hatsudoki Kabushiki Kaisha |
Cylinder head for engine
|
|
DE4423078B4
(de)
*
|
1994-07-01 |
2005-01-13 |
Awd.Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
|
|
GB2290965A
(en)
|
1994-07-11 |
1996-01-17 |
Therapicon Srl |
Multiple layer capsules for drugs
|
|
US6586006B2
(en)
*
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
|
US6156343A
(en)
*
|
1994-12-27 |
2000-12-05 |
Akzo Nobel N.V. |
Controlled release preparation
|
|
US5981592A
(en)
|
1995-03-13 |
1999-11-09 |
Loma Linda University Medical Center |
Method and composition for treating cystic fibrosis
|
|
US6214331B1
(en)
*
|
1995-06-06 |
2001-04-10 |
C. R. Bard, Inc. |
Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
|
|
DE19530575A1
(de)
*
|
1995-08-19 |
1997-02-20 |
Gruenenthal Gmbh |
Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
|
|
GB9519363D0
(en)
*
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
|
IL116281A
(en)
|
1995-12-07 |
1999-06-20 |
Chemagis Ltd |
Process for the purification of (rr,ss)-2-dimethylaminomethyl-1-(3-methoxyphenyl) cyclohexanol and its salts
|
|
IT1282650B1
(it)
*
|
1996-02-19 |
1998-03-31 |
Jagotec Ag |
Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
|
|
US5773031A
(en)
*
|
1996-02-27 |
1998-06-30 |
L. Perrigo Company |
Acetaminophen sustained-release formulation
|
|
CA2173818A1
(fr)
*
|
1996-04-10 |
1997-10-11 |
Francois Chouinard |
Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
|
|
IL119121A
(en)
*
|
1996-08-22 |
2000-11-21 |
Chemagis Ltd |
Process for the purification of (RR-SS)-2-dimethylaminomethyl-1-(3-methoxyphenyl)cyclohexanol hydrochloride
|
|
JPH1095801A
(ja)
*
|
1996-09-24 |
1998-04-14 |
Asahi Chem Ind Co Ltd |
高成形性セルロース粉末
|
|
DE19640062B4
(de)
*
|
1996-09-28 |
2006-04-27 |
Lts Lohmann Therapie-Systeme Ag |
Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff
|
|
EP0935523B1
(en)
|
1996-10-28 |
2004-09-29 |
Inc. General Mills |
Embedding and encapsulation of controlled release particles
|
|
US5879707A
(en)
*
|
1996-10-30 |
1999-03-09 |
Universite De Montreal |
Substituted amylose as a matrix for sustained drug release
|
|
EP0971690B2
(en)
*
|
1996-12-18 |
2015-04-01 |
Bimeda Research & Development Limited |
Antiinfective free intramammary veterinary composition
|
|
US5807575A
(en)
|
1997-02-14 |
1998-09-15 |
Rougier Inc. |
Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
|
|
ATE275394T1
(de)
|
1997-03-11 |
2004-09-15 |
Arakis Ltd |
R- und s- enantiomere getrennteteile enthaltende dosierungsformen
|
|
DE19710008A1
(de)
|
1997-03-12 |
1998-09-17 |
Basf Ag |
Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
|
|
BE1011045A3
(fr)
|
1997-03-14 |
1999-04-06 |
Ucb Sa |
Compositions pharmaceutiques pour la liberation controlee de substances actives.
|
|
US6077537A
(en)
*
|
1997-05-21 |
2000-06-20 |
Warner-Lambert Company |
Non-sedating acrivastine product
|
|
ATE322892T1
(de)
|
1997-07-02 |
2006-04-15 |
Euro Celtique Sa |
Stabilisierte tramadol formulierungen mit verzögerter freisetzung
|
|
US6120803A
(en)
|
1997-08-11 |
2000-09-19 |
Alza Corporation |
Prolonged release active agent dosage form adapted for gastric retention
|
|
FR2772615B1
(fr)
*
|
1997-12-23 |
2002-06-14 |
Lipha |
Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
|
|
US5877351A
(en)
*
|
1997-12-24 |
1999-03-02 |
Wyckoff Chemical Company, Inc. |
Preparation and purification process for 2- (dimethylamino) methyl!-1-(3-methoxphenyl)-cyclohexanol and its salts
|
|
WO1999038504A1
(en)
|
1998-01-29 |
1999-08-05 |
Sepracor Inc. |
Pharmaceutical uses of optically pure (-)-bupropion
|
|
US6284273B1
(en)
|
1998-02-24 |
2001-09-04 |
Vincent Lenaerts |
Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
|
|
US6245357B1
(en)
*
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
|
DK1073432T3
(da)
|
1998-04-14 |
2007-12-17 |
Gen Hospital Corp |
Anvendelse af D serin eller D alanin til behandling af skizofreni
|
|
US6156342A
(en)
|
1998-05-26 |
2000-12-05 |
Andex Pharmaceuticals, Inc. |
Controlled release oral dosage form
|
|
US6143325A
(en)
|
1998-06-05 |
2000-11-07 |
Bristol-Myers Squibb Company |
Nefazodone dosage form
|
|
AU765110B2
(en)
*
|
1998-06-26 |
2003-09-11 |
Georgetown University Medical Center |
Compositions and methods for inducing cell death
|
|
AU758019B2
(en)
|
1998-07-10 |
2003-03-13 |
U.S. Medical Research Institute Of Infectious Diseases |
Anthrax vaccine
|
|
DE19840152A1
(de)
*
|
1998-09-03 |
2000-03-09 |
Dresden Arzneimittel |
Calciumvalproat enthaltende pharmazeutische Zusammensetzungen mit retardierter Wirkstoff-Freisetzung, Verfahren zu deren Herstellung und deren Verwendung
|
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
|
WO2000025769A1
(en)
|
1998-11-02 |
2000-05-11 |
Ortho-Mcneil Pharmaceutical, Inc. |
Analgesic regimen
|
|
US6245387B1
(en)
*
|
1998-11-03 |
2001-06-12 |
Diamon-Fusion International, Inc. |
Capped silicone film and method of manufacture thereof
|
|
HUP0104420A2
(en)
|
1998-12-02 |
2002-08-28 |
Darwin Discovery Ltd |
Therapeutic composition containing a new form of tramadol and its use
|
|
US6129205A
(en)
|
1998-12-09 |
2000-10-10 |
Ashworth Bros. Inc. |
Variable loop count conveyor belt
|
|
US6498196B1
(en)
|
1998-12-22 |
2002-12-24 |
Edward Roberts |
Compounds useful in pain management
|
|
DE19901687B4
(de)
*
|
1999-01-18 |
2006-06-01 |
Grünenthal GmbH |
Opioide Analgetika mit kontrollierter Wirkstofffreisetzung
|
|
DE19901683B4
(de)
|
1999-01-18 |
2005-07-21 |
Grünenthal GmbH |
Analgetikum mit kontrollierter Wirkstofffreisetzung
|
|
PE20001396A1
(es)
*
|
1999-01-18 |
2000-12-23 |
Gruenenthal Chemie |
Formulaciones medicamentosas retardadas que contienen una combinacion de un opioide o una sal fisiologicamente tolerables del mismo, un o-agonista
|
|
DE19901686A1
(de)
|
1999-01-18 |
2000-07-20 |
Gruenenthal Gmbh |
Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung
|
|
US7450229B2
(en)
*
|
1999-01-25 |
2008-11-11 |
Amnis Corporation |
Methods for analyzing inter-cellular phenomena
|
|
JP2002535353A
(ja)
|
1999-01-29 |
2002-10-22 |
ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク |
医薬品組成物
|
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
DE19927688A1
(de)
*
|
1999-06-17 |
2000-12-21 |
Gruenenthal Gmbh |
Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
|
|
NZ517559A
(en)
*
|
1999-08-31 |
2004-08-27 |
Gruenenthal Chemie |
Sustained release pharmaceutical composition containing tramadol saccharinate
|
|
DE19940944B4
(de)
|
1999-08-31 |
2006-10-12 |
Grünenthal GmbH |
Retardierte, orale, pharmazeutische Darreichungsformen
|
|
DE10023699A1
(de)
|
1999-08-31 |
2001-04-19 |
Gruenenthal Gmbh |
Retardierte Darreichungsform enthaltend Tramadolsaccharinat
|
|
DE19940740A1
(de)
*
|
1999-08-31 |
2001-03-01 |
Gruenenthal Gmbh |
Pharmazeutische Salze
|
|
DE19947747A1
(de)
|
1999-10-05 |
2001-04-12 |
Gruenenthal Gmbh |
Verwendung von (+)-Tramadol, O-Demethyltramadol bzw. (+)-O-Demethyltramadol zur Therapie der Harninkontinenz
|
|
PE20010623A1
(es)
|
1999-10-05 |
2001-07-07 |
Gruenenthal Chemie |
Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
|
|
US6339105B1
(en)
*
|
1999-10-12 |
2002-01-15 |
Ortho-Mcneil Pharmaceutical, Inc. |
Analgesic regimen
|
|
SK287105B6
(sk)
|
1999-12-20 |
2009-12-07 |
Schering Corporation |
Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
|
|
US6211229B1
(en)
*
|
2000-02-17 |
2001-04-03 |
Neil B. Kavey |
Treatment of transient and short term insomnia
|
|
US6645537B2
(en)
|
2000-02-18 |
2003-11-11 |
Keurig, Incorporated |
Beverage filter cartridge
|
|
US6326404B1
(en)
|
2000-02-21 |
2001-12-04 |
Gruenenthal Gmbh |
Use of O-desmethyl-N-mono-desmethyl-tramadol
|
|
GB0007419D0
(en)
|
2000-03-27 |
2000-05-17 |
Smithkline Beecham Gmbh |
Composition
|
|
DE10014588A1
(de)
|
2000-03-27 |
2001-10-04 |
Basf Ag |
Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
|
|
DE10015479A1
(de)
|
2000-03-29 |
2001-10-11 |
Basf Ag |
Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
|
|
GB0009522D0
(en)
|
2000-04-19 |
2000-06-07 |
Smithkline Beecham Plc |
Composition
|
|
US6955821B2
(en)
|
2000-04-28 |
2005-10-18 |
Adams Laboratories, Inc. |
Sustained release formulations of guaifenesin and additional drug ingredients
|
|
JP2001353519A
(ja)
*
|
2000-06-14 |
2001-12-25 |
Suncall Corp |
二重構造クラッドパイプ及びその製造方法
|
|
DE10029201A1
(de)
*
|
2000-06-19 |
2001-12-20 |
Basf Ag |
Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
|
|
US6607748B1
(en)
|
2000-06-29 |
2003-08-19 |
Vincent Lenaerts |
Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
|
|
ES2228789T3
(es)
|
2000-09-22 |
2005-04-16 |
Smb Technology |
Composicion oral de tramadol en forma de granulados para tomar una vez por dia.
|
|
EP2932964A1
(en)
*
|
2000-10-30 |
2015-10-21 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
|
US20020106408A1
(en)
*
|
2000-12-01 |
2002-08-08 |
Johnatan Bacon |
Prolamin-based sustained-release compositions and delayed-onset compositions
|
|
US6287599B1
(en)
|
2000-12-20 |
2001-09-11 |
Shire Laboratories, Inc. |
Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
|
|
DE50113344D1
(de)
|
2001-01-31 |
2008-01-17 |
Evonik Roehm Gmbh |
Multipartikuläre arzneiform, enthaltend mindestens zwei unterschiedlich überzogene pelletformen
|
|
WO2002069974A1
(en)
|
2001-03-05 |
2002-09-12 |
Andrew Holman |
Administration of sleep restorative agents
|
|
US6806293B1
(en)
|
2001-03-12 |
2004-10-19 |
Darley Pharmaceuticals Ltd |
Use of pheromone compounds having MAP kinase modulating activity
|
|
US7858118B2
(en)
*
|
2001-04-11 |
2010-12-28 |
Galephar Pharmaceutical Research, Inc. |
Extended release composition containing Tramadol
|
|
US6659373B1
(en)
|
2001-05-30 |
2003-12-09 |
L. R. Nelson |
One touch actuated valve
|
|
US6968551B2
(en)
|
2001-06-11 |
2005-11-22 |
John Hediger |
System and user interface for generation and processing of software application installation instructions
|
|
US7842307B2
(en)
|
2001-08-06 |
2010-11-30 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
|
|
US20030068375A1
(en)
*
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
US20030092724A1
(en)
*
|
2001-09-18 |
2003-05-15 |
Huaihung Kao |
Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
|
|
AU2002351798A1
(en)
|
2001-10-29 |
2003-05-12 |
Labopharm Inc. |
Methods and dosage forms for improving the bioavailability of therapeutic agents
|
|
US6863901B2
(en)
*
|
2001-11-30 |
2005-03-08 |
Collegium Pharmaceutical, Inc. |
Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
|
|
US20060009465A1
(en)
*
|
2002-01-18 |
2006-01-12 |
Dale Edgar |
Treatment of sleep disorders using sleep target modulators
|
|
KR100540035B1
(ko)
|
2002-02-01 |
2005-12-29 |
주식회사 태평양 |
다단계 경구 약물 방출 제어 시스템
|
|
ES2377729T3
(es)
|
2002-02-21 |
2012-03-30 |
Valeant International (Barbados) Srl |
Formulaciones de liberación modificada de al menos una forma de tramadol
|
|
IL164077A0
(en)
|
2002-03-22 |
2005-12-18 |
Cilag Ag |
Sustained release formulation of tramadol
|
|
AU2003232805A1
(en)
|
2002-05-24 |
2003-12-12 |
Carl-Fr. Coester |
Pharmaceutical active substance combination and the use thereof
|
|
US7562089B2
(en)
*
|
2002-06-26 |
2009-07-14 |
Seagate Technology Llc |
Systems and methods for storing information to allow users to manage files
|
|
FR2841717B1
(fr)
|
2002-06-28 |
2004-09-10 |
Bouygues Telecom Sa |
Procede de saisie de messages
|
|
DE60319252T2
(de)
*
|
2002-09-21 |
2009-03-05 |
Zhang, Shuyi |
Formulierung von acetaminophen und tramadol mit verzögerter freisetzung
|
|
SE0203065D0
(sv)
*
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
|
US8487002B2
(en)
|
2002-10-25 |
2013-07-16 |
Paladin Labs Inc. |
Controlled-release compositions
|
|
RU2333745C2
(ru)
|
2002-10-25 |
2008-09-20 |
Лабофарм Инк. |
Композиции с контролируемым высвобождением
|
|
TWI319713B
(en)
*
|
2002-10-25 |
2010-01-21 |
|
Sustained-release tramadol formulations with 24-hour efficacy
|
|
CA2503155A1
(en)
|
2002-10-25 |
2004-05-06 |
Labopharm Inc. |
Sustained-release tramadol formulations with 24-hour efficacy
|
|
US6669929B1
(en)
*
|
2002-12-30 |
2003-12-30 |
Colgate Palmolive Company |
Dentifrice containing functional film flakes
|
|
US7413749B2
(en)
|
2003-03-11 |
2008-08-19 |
Purdue Pharma L.P. |
Titration dosing regimen for controlled release tramadol
|
|
WO2004082684A1
(en)
*
|
2003-03-17 |
2004-09-30 |
Acorda Therapeutics |
Stable oral formulations of aminopyridines and uses thereof
|
|
US20060172006A1
(en)
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
|
US8007826B2
(en)
|
2003-12-11 |
2011-08-30 |
Acorda Therapeutics, Inc. |
Sustained release aminopyridine composition
|
|
US20050157382A1
(en)
*
|
2004-01-07 |
2005-07-21 |
Kafka James D. |
Industrial directly diode-pumped ultrafast amplifier system
|
|
WO2006055672A2
(en)
|
2004-11-16 |
2006-05-26 |
Limerick Neurosciences, Inc. |
Methods and compositions for treating pain
|
|
WO2006069293A2
(en)
*
|
2004-12-22 |
2006-06-29 |
Friedman Robert S |
Composition comprising n-acetylcysteine and further pain or anti- inflamm medications
|
|
US20060193912A1
(en)
|
2005-02-28 |
2006-08-31 |
Penwest Pharmaceuticals Co. |
Controlled release O-desmethylvenlafaxine formulations
|
|
JP2009506059A
(ja)
*
|
2005-08-24 |
2009-02-12 |
ペンウエスト ファーマシューティカルズ カンパニー |
ナルブフィンの徐放性製剤
|
|
CN101242856A
(zh)
*
|
2005-09-09 |
2008-08-13 |
莱博法姆公司 |
持续药物释放的组合物
|
|
DK1931346T3
(da)
*
|
2005-09-09 |
2012-10-22 |
Angelini Labopharm Llc |
Trazodonsammensætning til indgivelse en gang om dagen
|
|
US20070237816A1
(en)
|
2006-04-06 |
2007-10-11 |
David Finkelstein |
Acetaminophen formulation for joint pain relief
|
|
FR2928836B1
(fr)
|
2008-03-21 |
2011-08-26 |
Servier Lab |
Forme galenique secable permettant une liberation modifiee du principe actif
|
|
AU2009282376A1
(en)
|
2008-08-12 |
2010-02-18 |
Inspirion Delivery Technologies, Llc |
Pharmaceutical compositions configured to deter dosage form splitting
|